Quantitative Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

Quantitative Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $563,610 - $733,934	-14,265 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $368,179 - $622,239	14,265 New	14,265 $609,000
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $608,030 - $699,919	-23,622 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $383,857 - $633,305	23,622 New	23,622 $633,000
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $3.08 Million - $4.84 Million	-221,558 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $3.31 Million - $4.33 Million	221,558 New	221,558 $3.93 Million
Q4 2018 Feb 12, 2019	SELL	$13.33 - $18.66 $177,289 - $248,178	-13,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.68 - $18.41 $221,844 - $244,853	13,300 New	13,300 $241,000
Q2 2018 Aug 10, 2018	SELL	$16.87 - $20.3 $814,821 - $980,490	-48,300 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $1.53 Million - $1.9 Million	-89,800 Reduced 65.03%	48,300 $946,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $2.31 Million - $2.87 Million	138,100	138,100 $2.8 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.